Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026)
Powered by 
Analysis
Theravance Biopharma (TBPH) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 882.99 Mn | 495.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38,439.00 |
| Mar 31, 2026 | 52,073.00 |
| Dec 31, 2025 | 60,791.00 |
| Sep 30, 2025 | 38,841.00 |
| Jun 30, 2025 | 69,823.00 |
| Mar 31, 2025 | 32,553.00 |
| Dec 31, 2024 | -3,109.00 |
| Sep 30, 2024 | 45,528.00 |
| Jun 30, 2024 | -3,337.00 |
| Mar 31, 2024 | 128,646.00 |
| Dec 31, 2023 | 31,104.00 |
| Sep 30, 2023 | 41,976.00 |
| Jun 30, 2023 | 9,961.00 |
| Mar 31, 2023 | 56,483.00 |
| Dec 31, 2022 | 167,305.00 |
| Sep 30, 2022 | 141,538.00 |
| Jun 30, 2022 | 166,980.00 |
| Mar 31, 2022 | 164,045.00 |
| Dec 31, 2021 | 64,458.00 |
| Sep 30, 2021 | -25,002.00 |